Holm, Julia Elvira Johanna
Ruppert, Jan Gustav
Ramsden, Samuel David
Article History
Accepted: 5 December 2021
First Online: 31 January 2022
Declarations
:
: No honoraria or payments were made for authorship. Open access fee was paid by Boehringer Ingelheim International GmbH.
: Julia E. J. Holm, Jan G. Ruppert and Samuel D. Ramsden are employed by Boehringer Ingelheim International GmbH. No other potential conflict of interest relevant to this article was reported.
: Not applicable.
: Not applicable.
: Not applicable.
: Data about specific products are available upon request and via European Public Assessment Reports published by the European Medicines Agency".
: Not applicable.
: All authors contributed to the study conception and design. The Literature review was performed by Julia E.J. Holm. Data collection and analysis were performed by Julia E.J. Holm for Products A, B, D, E, F and G. Jan G. Ruppert collected and analysed the data for Product C. Samuel D. Ramsden provided strategic direction for the data analysis and conclusions. The manuscript was written by Julia E.J. Holm. All authors reviewed the previous versions of the manuscript. All authors read and approved the final manuscript.